glyoxylate and hydroxypyruvate reductase
Última atualização 3 Apr 2025
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
A GRHPR gene provides instructions for making an enzyme called glyoxylate and hydroxypyruvate reductase. This enzyme plays a role in preventing the buildup of a potentially harmful substance called glyoxylate by converting it to a substance called glycolate, which is easily excreted from the body. Additionally, this enzyme can convert a compound called hydroxypyruvate to D-glycerate, which is eventually converted to the simple sugar glucose (by other enzymes) and used for energy.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
A GRHPR gene provides instructions for making an enzyme called glyoxylate and hydroxypyruvate reductase. This enzyme plays a role in preventing the buildup of a potentially harmful substance called glyoxylate by converting it to a substance called glycolate, which is easily excreted from the body. Additionally, this enzyme can convert a compound called hydroxypyruvate to D-glycerate, which is eventually converted to the simple sugar glucose (by other enzymes) and used for energy.
Conditions referring to this gene or chromosome
Other names
D-glycerate dehydrogenase
GLXR
glyoxylate reductase/hydroxypyruvate reductase
GRHPR_HUMAN
PH2
Related patient information and medicines

Patient information leaflet
Verifique se seus medicamentos têm interações
Use this medicine and drug interaction checker para see whether your medicines, supplements, vitamins, foods, or certain health conditions may interact with each other. It can help you understand potential risks, avoid unwanted side effects, and decide when it’s important to speak to a pharmacist, GP, or other healthcare professional. The tool is.

Patient information leaflet
Refluxo ácido e esofagite
When acid from the stomach leaks up into the oesophagus (tube carrying the food from the mouth to the stomach) the condition is known as acid reflux. What is acid reflux. Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info When acid from the stomach leaks up into the gullet (oesophagus), the condition is known as acid reflux. This may.

Patient information leaflet
Próstata aumentada
Este aumento da glândula prostática is also called hipertrofia prostática benigna (or hyperplasia). It can cause problems with passing urine. Symptoms are often mild. Alpha-blocker medicines Alpha-blockers. These medicines work by relaxing the smooth muscle of the prostate and bladder neck. This can improve the flow of urine. 5-alpha reductase inhibitor.

Patient information leaflet
síndrome de Sjögren
síndrome de Sjögren é um autoimmune disease that causes the glands that produce tears and saliva para stop working. It is a life-long condition but treatments can help control symptoms such as dry eyes and dry mouth. Key points Sjögren’s syndrome is an autoimmune condition where the immune system attacks glands that produce moisture, mainly the tear.

Patient information leaflet
Sangue no sêmen
Hematospérmia means there is blood in the semen. Medicines If you have persistent haematospermia without an identified cause then a type of medicine called a 5-alpha reductase inhibitor tais como finasteride Finasteride for prostate gland enlargement or dutasteride Dutasteride for prostate gland enlargement may be effective. For younger men with.

Patient information leaflet
Problemas de próstata
This leaflet will give you a brief explanation of the different próstata e urethral conditions and how the urine system can be affected. There are various treatments for the symptoms of BPH, including drugs such as alfuzosin/doxazosin (alpha-blockers), dutasteride/finasteride (5-alpha reductase inhibitors),.
Leitura adicional e referências
- glyoxylate and hydroxypyruvate reductase; MedlinePlus, National Library of Medicine.
- Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013 Aug 15;369(7):649-58. doi: 10.1056/NEJMra1301564. No abstract available.
- Cregeen DP, Williams EL, Hulton S, Rumsby G. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. Hum Mutat. 2003 Dec;22(6):497. doi: 10.1002/humu.9200.
- Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012 Jun 12;8(8):467-75. doi: 10.1038/nrneph.2012.113.
- Knight J, Holmes RP. Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria. Am J Nephrol. 2005 Mar-Apr;25(2):171-5. doi: 10.1159/000085409. Epub 2005 Apr 21.
- Rumsby G, Hulton SA. Primary Hyperoxaluria Type 2. 2008 Dec 2 [updated 2017 Dec 21]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK2692/
- Webster KE, Ferree PM, Holmes RP, Cramer SD. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet. 2000 Aug;107(2):176-85. doi: 10.1007/s004390000351.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

